Recurrence of hepatitis c in liver transplant recipients treated with mycophenolate mofetil

By Fasola C.G.   Netto G.J.   Jennings L.W.   Christensen L.L.   Molmenti E.P.   Sanchez E.Q.   Levy M.F.   Goldstein R.M.   Klintmalm G.B.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1563-1564

Elsevier

Access to resources Recommend Favorite

Hepatitis C Recurrence in Liver Transplant Recipients

By Kizilisik T.A.   Al-Sebayel M.   Hammad A.   Al-Traif I.   Ramirez C.G.   Abdulla A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2875-2877

Elsevier

Access to resources Recommend Favorite

Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients

By Demirbas A.   Tuncer M.   Yavuz A.   Gurkan A.   Kacar S.   Cetinkaya R.   Tekin S.   Akbas S.H.   Akaydin M.   Ersoy F.   Yakupoglu G.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 175-177

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Inigo V.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2259-2260

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil/neoral/steroid vs neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients

By Carmellini M.   Vistoli F.   Bellini R.   Boggi U.   Rindi P.   Rizzo G.   Mosca F.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1162-1164

Elsevier

Access to resources Recommend Favorite